Profile: Neurosearch A/S (NEUR.CO)
NEUR.CO on Copenhagen Stock Exchange
Price Change (% chg)
NeuroSearch A/S is Denmark-based biopharmaceutical company. It is primarily engaged in the Research and Development, registration, marketing and sale of treatments for diseases and disorders affecting the Central Nervous System (CNS), such as Huntington’s, Parkinson’s and Alzheimer’s diseases, as well as pain, epilepsy and psychiatric disorders, such as depression, anxiety, Attention-Deficit Hyperactivity Disorder (ADHD) and schizophrenia. The Company bases its treatments principally on ion channel modulation and monoamine systems. As of December 31, 2011, the Company operated through three wholly owned subsidiaries, NeuroSearch Sweden AB, Poseidon Pharmaceutical A/S and NsExplorer A/S.